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To determine the change in walking gait biomechanics after total hip arthroplasty (THA) for 31 
osteoarthritis (OA) compared to the pre-operative gait status, and to compare the recovery 32 
of gait following THA with healthy individuals.  33 
Methods 34 
Systematic review with meta-analysis of studies investigating changes in gait biomechanics 35 
after THA compared to (1) preoperative levels and (2) healthy individuals. Data were pooled 36 
at commonly reported time points and standardised mean differences (SMDs) were 37 
calculated in meta-analyses for spatiotemporal, kinematic and kinetic parameters. 38 
Results 39 
Seventy-four studies with a total of 2477 patients were included. At 6 weeks postoperative, 40 
increases were evident for walking speed (SMD: 0.32, 95% CI 0.14, 0.50), stride length (SMD: 41 
0.40, 95% CI 0.19, 0.61), step length (SMD: 0.41, 95% CI 0.23, 0.59), and transverse plane hip 42 
range of motion (ROM) (SMD: 0.36, 95% CI 0.05, 0.67) compared to pre-operative gait. 43 
Sagittal, coronal and transverse hip ROM was significantly increased at 3 months (SMDs: 44 
0.50 to 1.07). At 12 months postoperative, patients demonstrated deficits compared with 45 
healthy individuals for walking speed (SMD: -0.59, 95% CI -1.08 to -0.11), stride length (SMD: 46 
-1.27, 95% CI -1.63, -0.91), single limb support time (SMD: -0.82, 95% CI -1.23, -0.41) and 47 
sagittal plane hip ROM (SMD: -1.16, 95% CI -1.83, -0.49). Risk of bias scores ranged from 48 
















Following THA for OA, early improvements were demonstrated for spatiotemporal and 51 
kinematic gait patterns compared to the pre-operative levels.  Deficits were still observed in 52 
THA patients compared to healthy individuals at 12 months.   53 
Keywords 54 




















Osteoarthritis (OA) of the hip is a common chronic condition responsible for significant pain 2 
and disability, with approximately 4 to 9% of adults over the age of 45 living with 3 
symptomatic hip OA 
1, 2
. Diagnosis of symptomatic OA is the principal indication for total hip 4 
arthroplasty (THA), which is the treatment for individuals with end-stage OA when 5 
conservative therapies to manage symptoms have been exhausted. The demand for THA is 6 
estimated to rise substantially in the next decade, to approximately half a million primary 7 
THAs per year by 2030 in the United States 
3
. Hip OA commonly affects a patient’s function 8 
causing difficulty in walking where altered gait biomechanics are observed, particularly in 9 
individuals with severe stage disease who are candidates for THA 
4
. Whilst THA is a 10 
successful procedure, attributed to the long-term survivorship of the implant and alleviation 11 
of chronic joint pain, aberrant pre-operative gait patterns may persist following THA, 12 
despite improvements in self-reported measures of pain and physical function 
5, 6
. 13 
Two recent systematic reviews 
7, 8
 compared outcomes in walking gait following primary 14 
THA to that of healthy individuals and identified lower walking speed and stride length, 15 
lower sagittal and coronal plane hip joint range of motion, and lower peak hip abduction 16 
moment. Whilst these reviews provide a recent comparison of THA patients to that of 17 
healthy individuals, the pre-operative functional status of patients were not considered. The 18 
nature of gait abnormalities prior to the joint replacement must be considered due to the 19 
association between pre- and post-operative gait status 
9
. Furthermore, reporting of post-20 
operative gait abnormalities compared with healthy individuals may inadequately represent 21 
the changes after THA if relative change to pre-operative status is not considered as end-22 


















which may persist following surgery 
5
. A range of time points, from 6 weeks to 24 months 24 
10,11
 have been used to investigate changes in gait biomechanics following THA for OA. To 25 
date, no review has synthesised the available evidence at commonly reported time points to 26 
identify the change from pre- to post-operative gait in people with OA following THA, and 27 
compare the results to healthy individuals to better understand the trajectory of change and 28 
recovery in gait function after THA.  Therefore, the aims of this systematic review were to 29 
determine the change in gait biomechanics after THA compared to the pre-operative gait 30 
status; and to compare the recovery of gait following THA with healthy individuals.  31 
Methods 32 
The findings of this review are reported in accordance with the Preferred Reporting Items 33 
for Systematic Reviews and meta-analyses (PRISMA) statement guidelines (Supplementary 34 
File 1)
 13
. The protocol for the review was registered with the International Prospective 35 
register for Systematic Reviews (PROSPERO; registration no. CRD 42016035904).  36 
Search strategy  37 
The PICO (Population, Intervention, Comparison and Outcome) framework was used to 38 
define the search strategy, in consultation with an academic librarian 
14
. An electronic 39 
search of the following databases was performed with no date restrictions: PubMed, 40 
MEDLINE, CINAHL, The Cochrane Library, Embase, Scopus, Web of science, SportDiscus and 41 
Health collection. Keywords were matched with exploded MeSH terms to generate themes 42 
around total hip arthroplasty, biomechanics and gait (Supplementary File 2). Variations of 43 
electromyography and stair climbing were included as an outcome in the search as it was 44 
anticipated walking gait data might be included in studies of this kind. Database searching 45 


















articles retrieved from each database before proceeding. Search alerts were created for 47 
each database to identify articles published after the initial search (up to January 1, 2017). 48 
Conference abstracts and reference lists of review and final included articles were manually 49 
searched to identify additional articles. Citations retrieved from the searches were uploaded 50 
to an online systematic review platform (Covidence) 
15
 for screening. Two reviewers (JB and 51 
MN) independently screened titles and abstracts and any conflicts were resolved by 52 
discussion, or by the opinion of a third researcher (JA) if consensus was not reached. Titles 53 
that met the eligibility criteria were then obtained as full manuscripts and reviewed 54 
independently by two reviewers (JB and MN). Disagreements were managed using the same 55 
process from the screening stage.  56 
Eligibility criteria 57 
Articles were eligible for inclusion in this review when they satisfied the following criteria: 58 
(1) adults aged ≥18 years undergoing primary unilateral THA; (2) osteoarthritis was the 59 
primary indication for THA; (3) studies reporting the change in gait biomechanics 60 
(spatiotemporal, kinematics, kinetics) from pre- to post-operative or comparing THA 61 
patients following surgery to matched healthy individuals; (4) 2D or 3D motion analysis 62 
techniques (including ground reaction forces) were used to measure level walking at a self-63 
selected speed; and (5) participants could perform the task unaided. Studies using motion 64 
capture systems, force platforms, accelerometers, instrumented treadmills or instrumented 65 
shoes were all included in this review. Spatiotemporal data collected from a hand-held 66 
timepiece (e.g. stopwatch) were excluded. Studies investigating the effect of physical 67 
rehabilitation on gait outcomes were excluded unless they included a conventional THA 68 


















undergo THA (e.g. hip resurfacing) or participants with a history of other lower limb joint 70 
disease or surgeries (knee, ankle or contralateral hip) were not eligible.  71 
Outcome measures and data extraction  72 
A custom data-extraction spreadsheet was used to extract numerical data from all studies. 73 
The first author extracted the data (JSB), and a second author (JBA) verified the data were 74 
extracted accurately from the studies that were used in the meta-analysis. The primary 75 
outcome measures for this review were spatiotemporal, kinematic (joint angles) and kinetic 76 
parameters (e.g. external joint moments) reported during level walking. Means and 77 
standard deviations for all gait parameters were extracted for the pre-operative and follow-78 
up time points, and from healthy control groups, when available. Extraction of joint 79 
kinematic and kinetic parameters were limited to the affected hip. The following 80 
information on patient and surgical characteristics was also extracted from each study: 81 
study design, sample size, age, gender, BMI, severity of osteoarthritis, and surgical 82 
approach.  83 
Data synthesis and analysis  84 
As numerous gait variables across multiple time points were expected, a structured process 85 
was undertaken to synthesise the results on the most commonly reported variables and 86 
time-points. Studies typically report a mean follow-up or multiple post-operative time 87 
points at six weeks, three months, six months and 12 months. Where studies reported a 88 
mean that was close to these time points (within one week for time points <6 months, and 3 89 
months for time points >6 months) data were merged to the closest common time-point to 90 


















When adequate data were reported, standardized mean differences (SMDs) were calculated 92 
using the pooled standard deviation for the biomechanical parameters between either the 93 
pre and post-operative time points (preoperative as the reference) or postoperative versus 94 
control group. Where not available, the standard error of the mean difference were 95 
estimated from P values using the equivalent T-statistic 
16
. When this was not possible, the 96 
standard error of the mean difference was estimated using the most conservative 97 
correlation estimate from other studies 
16
, and the stability of this approach was assessed 98 
through a sensitivity analysis where the correlation estimate was set to zero to determine 99 
the impact on the magnitude of the pooled effect. Where study results were reported as 100 
medians and ranges or interquartile ranges, authors were contacted twice to obtain the 101 
mean and standard deviation (SD). When not provided, data were transformed to the mean 102 
and SD 
17
. For the meta-analysis, pooled estimates and 95% confidence intervals (CI) for 103 
standardised mean differences were calculated using a random effects model in Review 104 
Manager software (RevMan, v5.2, Cochrane Collaboration, Oxford UK). Statistical 105 
significance was set at P < 0.05. All data were extracted and the pooled effect size estimates 106 
were computed when at least two studies reported the same gait variable at the same time 107 
point.  The magnitude of the overall effect was quantified as trivial (<0.2), small (0.2-0.6), 108 
moderate (0.61-1.2), large (1.21-2.0) and very large (>2.0) 
17
. Where studies presented data 109 
on more than one surgical approach instead of the entire THA cohort, a separate effect size 110 
was determined for each surgical group 
17
.  111 
Heterogeneity was assessed using the I
2 





was statistically significant (P <0.05), potential explanatory variables contributing to 113 


















characteristics identified a priori including age, BMI, sample size, surgical approach, gender 115 
and risk of bias score. The regression was only performed when ≥ 10 studies reported on a 116 
gait parameter at a time point 
19
.  Potential publication bias was examined using contour 117 
enhanced funnel plots and Egger’s regression test using STATA (v14, Statacorp, USA). 118 
Methodological risk of bias 119 
Methodological risk of bias of studies was performed through merging three established 120 




. The recommended scoring criteria from each tool were maintained resulting in a total 122 
of 20 items with a possible maximum score range of 0 to 26, with higher scores indicating a 123 
reduced risk of bias. The scoring was carried out by two independent reviewers (JB and 124 
MN), with any disagreements resolved with the opinion of a third reviewer if required. Inter-125 
rater agreement for each item of the risk of bias tool was evaluated using the Kappa (ĸ) 126 
statistic. The risk of bias scores was included in the meta-regression to investigate if study 127 
bias contributed to heterogeneity.  Based on the results of the meta-analysis (effect size), 128 
statistical heterogeneity (I
2
) and risk of bias scores, of the strength of evidence for changes 129 
in each outcome variable at each time point was designated as per Van Tulder et al 2003 
23
: 130 
(1) strong evidence derived from three or more studies, including a minimum of two high-131 
quality studies that were statistically homogenous (I
2
 P ≥ 0.05); (2) moderate evidence 132 
derived from multiple studies that were statistically heterogeneous and where the pooled 133 
result was statistically significant, including at least one high-quality study from the risk of 134 
bias score; or from multiple moderate or low-quality studies which were statistically 135 
homogenous; (3) limited evidence provided by results from one high-quality study or 136 


















very limited evidence provided by results from one moderate-quality or low-quality study; 138 
and (5) no evidence where the pooled effect was insignificant and derived from multiple 139 
statistically heterogeneous studies (regardless of study quality from the risk of bias score).  140 
Results 141 
Study selection and characteristics 142 
The electronic database search yielded 3415 articles. After applying the eligibility criteria 143 
and searching of reference lists, 74 studies were retained and 46 were included in the meta-144 
analysis (Figure 1). Of the 74 included studies, 21 were prospective cohort studies, 21 case 145 
series studies, 29 case-control studies, and three randomised controlled trials (Table 1).   146 
Patient and surgical characteristics 147 
There were 2477 patients from 74 studies with a mean age of 59.7 SD 7.4 years, body mass 148 
index (BMI) of 28.7 SD 3.6 kg/m
2
 and 46% were female (Table 1). Post-operative follow-up 149 
ranged from 2 days to 6 years, with the most common time-points being 6 weeks, 3 months, 150 
6 months, 12 months and 24 months. Only two studies 
24, 25
 reported the radiographic 151 
severity of OA prior to surgery 
26
. The direct lateral and posterior surgical approaches were 152 
the most frequently used among the included studies (n=17 and n=16, respectively), 153 
followed by the anterolateral (n=13) and direct anterior (n=10).  154 
Outcome measures 155 
A total of 20 spatiotemporal, 56 kinematic and 54 kinetic variables were identified (Figure 156 
1). A total of 9 spatiotemporal and 6 kinematic variables met the requirements for meta-157 
analysis in pre-post comparisons, while 8 variables for both domains met the criteria for 158 


















postoperative THA patients to healthy controls (peak hip abduction moment). Five authors 160 
provided extra data upon request 
27, 28, 29, 30, 31
.   A summary of findings for each gait 161 
parameter in the meta-analysis at each time-point is provided in Table 2, with detailed 162 
information on the magnitude of effects and strength of evidence provided below. 163 
Spatiotemporal: comparison to pre-operative level 164 
Pooled data indicated there was moderate evidence of increased walking speed at 6 weeks 165 
(SMD: 0.32, P = 0.0006), 3 months (SMD: 0.78, P < 0.001) and 6 months (SMD: 0.97, P < 166 
0.001), with large changes at 12 months (SMD: 1.28, P < 0.001) (Figure 2A). At 6 weeks, 167 
there was a small change in step length (SMD 0.41, P <0.001) (Figure 3A) and stride length 168 
(SMD: 0.40, P < 0.001) (Supplementary File 3), which was also present at 3 months (SMD: 169 
0.52, P < 0.001; and SMD: 0.63, P < 0.001), with larger changes in step length at 6 months 170 
(SMD: 0.90, P < 0.001). There were trivial changes in step width at 6 weeks (SMD: -0.07, P = 171 
0.57) and 3 months (SMD: 0.02, P = 0.96), with moderate evidence from five studies to 172 
suggest that cadence did not change at 6 months (SMD: -0.08, P = 0.87) (Supplementary File 173 
3).  174 
Spatiotemporal: comparison to controls 175 
At 6 weeks post-THA there was moderate evidence demonstrating a large deficit in walking 176 
speed in THA patients compared with healthy individuals (SMD: -1.81, P < 0.001), which 177 
persisted but reduced in magnitude at 3 months (SMD: -1.22, P < 0.001), 6 months (SMD: -178 
0.69, P < 0.001), and 12 months (SMD: -0.59, P = 0.02).  Two studies provided limited 179 
evidence of a small deficit in walking speed at 24 months (SMD: -0.57, P < 0.007) (Figure 2B).  180 
Deficits of reducing magnitude were observed in step length compared to healthy 181 


















months (SMD: -0.35, P = 0.04), also persisting at 12 months post-THA (SMD: -0.54, P = 0.25) 183 
(Figure 3B). Marked deficits in stride length were also evident, with large effect sizes at 6 184 
weeks (SMD: -1.90, P < 0.001) and 3 months (SMD: -1.60, P < 0.001) with a large 185 
improvement in THA patients between 3 and 6 months, but still a moderate deficit at 6 186 
months (SMD: -0.78, P < 0.001). However, the same magnitude was not observed as 187 
compared to healthy individuals at 12 months (SMD: -1.27, P < 0.001). 188 
Three studies provided moderate evidence for a very large increase in double support time 189 
at 6 weeks (SMD: 2.22, P < 0.03), however, patients were comparable to healthy individuals 190 
at 3 months (SMD: -0.28, P = 0.77), 6 months (SMD: 0.18, P = 0.60), and 12 months (SMD: -191 
0.38, P = 0.10). Large increases in step width compared to healthy controls were evident at 6 192 
weeks (SMD: 1.33, P < 0.001) and 3 months (SMD: 1.90, P = 0.004).  193 
Kinematic: comparison to pre-operative level 194 
Moderate evidence from four studies demonstrated small changes in sagittal plane hip ROM 195 
compared to pre-operative level at 6 weeks (SMD: 0.49, P = 0.22), with a moderate increase 196 
at 3 months (SMD: 1.07, P = 0.006) (Figure 4A). There was no change in coronal plane hip 197 
ROM at 6 weeks (SMD: 0.33, P = 0.22) and 12 months (SMD: 0.33, P = 0.22), with moderate 198 
evidence of a significant increase at 3 months (SMD: 1.03, P = 0.01) (Figure 5A). Pooled 199 
results indicated a small increase in transverse plane hip ROM at 6 weeks (SMD: 0.36, P = 200 
0.02), 3 months (SMD: 0.50; P = 0.05) and 12 months (SMD: 0.36, P = 0.02) (Supplementary 201 
File 3). Two studies provided moderate evidence of a small decrease in peak hip abduction 202 
angle at 3 months (SMD: -0.39, P < 0.001). Moderate evidence indicated no significant 203 
change in peak hip flexion at 3 months (SMD: 0.16, P = 0.63) and coronal plane pelvic 204 


















Kinematic: comparison to controls 206 
Very large deficits in sagittal plane hip ROM compared to healthy individuals were observed 207 
at 6 weeks (SMD: -2.59, P < 0.001), decreasing in magnitude but persisting at 3 months 208 
(SMD: -1.88, P < 0.001), 6 months (SMD: -1.33, P < 0.001) and 12 months (SMD: -1.16, P < 209 
0.001) (Figure 4B). This also occurred for coronal plane hip ROM, with large deficits at 6 210 
weeks (SMD: -1.76, P < 0.001) and 3 months (SMD: -1.41, P < 0.001) (Figure 5B). There were 211 
negligible changes in transverse plane hip ROM compared to healthy individuals at 6 weeks 212 
(SMD: 0.18, P = 0.39) and 3 months (SMD: 0.26, P = 0.56). 213 
Moderate evidence from five studies demonstrated a significant increase in sagittal plane 214 
pelvis ROM compared to healthy individuals with a small effect at 12 months (SMD: 0.48, P 215 
= 0.05). THA patients were comparable to healthy individuals for coronal plane pelvic 216 
obliquity angle at 3 months (SMD: -0.20, P = 0.90), 6 months (SMD: 0.28, P = 0.67), and 12 217 
months (SMD: 0.09, P = 0.75) (Supplementary File 3).  218 
Kinetic: comparison to controls 219 
Four studies provided moderate evidence demonstrating THA patients were comparable to 220 
healthy individuals for peak hip abduction moment at 3 months (SMD: 0.02, P = 0.92). There 221 
was insufficient data to compare the change from pre-operative status. 222 
Meta-regression and sensitivity analysis 223 
Pooled analyses for velocity (6 weeks, 3 and 12 months), as well as step length and stride 224 
length (6 weeks), indicated high statistical heterogeneity (P < 0.05) with greater than 10 225 
studies reporting data at each time point. Among these factors, there was an association 226 


















association between step length effect size and study sample size at 6 weeks. No association 228 
was found for BMI, anterior surgical approach, gender or risk of bias score (Table 3). The 229 
sensitivity analysis revealed no change in the magnitude of the overall effect and the level of 230 
significance when the correlation estimates were zero (Supplementary file 5). 231 
Risk of publication bias 232 
Egger’s regression test demonstrated no evidence of publication bias for velocity at 6 weeks 233 
(β= 1.04, P = 0.368), 3 months (β = 1.6, P = 0.144), and 12 months (β = 1.4, P = 0.361) or for 234 
stride and step length at 6 weeks (β = 2.00, P = 0.657; β = 2.46, P = 0.187, respectively).  235 
Risk of methodological bias 236 
Inter-rater agreement for risk of bias scoring was high (ĸ = 0.77). Of a possible maximum 26 237 
points, the mean risk of bias score across studies was 18, SD = 4 (range = 7 to 24). 238 
Inadequate reporting of the sampling methods for recruitment (item 4), post-operative 239 
rehabilitation protocol (item 9), and number and characteristics of patients lost to follow-up 240 
(item 19) was common. Full risk of bias scoring is provided in Supplementary File 4. 241 
Discussion 242 
The aims of this systematic review were to determine the change in gait biomechanics after 243 
THA compared to the pre-operative gait status; and to compare the recovery of gait 244 
following THA with healthy individuals. This review identified evidence for moderate to large 245 
pre to post-operative changes from 6 weeks to 12 months in spatiotemporal and kinematic 246 
parameters. Compared to healthy individuals, although selected gait parameters appeared 247 
to normalise after THA, residual deficits in walking speed, stride length and sagittal plane hip 248 


















Relatively consistent improvements were demonstrated over time in walking velocity, step 250 
length and stride length following THA compared to pre-operative levels. The observed 251 
changes in gait velocity following surgery in this meta-analysis did not meet the meaningful 252 
clinically important improvements in gait velocity stated by Foucher et al. (2016) 
32
. Early 253 
improvements after THA were evident for walking speed, step length, stride length, and 254 
single-limb support time at 6 weeks, with improvements relative to before surgery 255 
demonstrated up to 12 months.  Despite these observed improvements in spatiotemporal 256 
parameters compared to the pre-operative status, patients were only comparable to 257 
healthy individuals for step length, which demonstrated early recovery and return to normal 258 
function from 6 weeks post-surgery. Importantly, despite early changes and significant 259 
improvements in walking speed for up to 12 months post-surgery, lower walking speed is 260 
still present at 12 months compared to healthy individuals. Step width was wider compared 261 
to healthy individuals at 6 weeks and 3 months indicating patients continue to demonstrate 262 
a wider based of support during gait after surgery.  263 
The kinematic data revealed increases in sagittal plane hip ROM and transverse plane hip 264 
ROM compared to pre-operative function at 6 weeks and up to 12 months. Despite 265 
continuous improvements following THA for sagittal plane hip ROM, reduced hip ROM in 266 
THA patients compared to healthy individuals at 12 months was evident. This may be due to 267 
an increase in pelvis and/or trunk flexion developed as a strategy to avoid pain before 268 
surgery 
34
, and potentially maintained following THA 
5
. Coronal plane hip 269 
abduction/adduction revealed no significant change from pre-operative status up to 12 270 
months post THA, with a significantly lower coronal plane hip ROM compared to healthy 271 


















reasons including muscle weakness in the affected limb due to pain and impaired function 273 
before surgery 
33
, and incision of the abductor muscles during surgery 
34
.  Pelvic obliquity 274 
ROM was comparable to healthy individuals from 3 months and maintained up to 12 275 
months.   276 
A meta-regression was performed to identify possible explanations for the observed 277 
heterogeneity in the gait parameters of velocity, stride length and step length. Only age was 278 
associated with effect size of walking speed at 3 months and 12 months post-operatively, 279 
indicating younger patients were associated with earlier recovery. The study sample size 280 
was related to effect size heterogeneity for step length at 6 weeks, with larger sample sizes 281 
showing a smaller effect for increased step length compared to pre-operative gait.  282 
Despite previous systematic reviews describing the deficient gait parameters in patients 283 
following THA compared to healthy individuals 
7, 8
 the pre-operative gait was not considered 284 
to determine the trend in recovery. This meta-analysis has for the first time, concurrently 285 
mapped the recovery in gait biomechanics after THA and compared postoperative status to 286 
healthy controls up to 2 years after surgery.  A greater number of longitudinal cohort studies 287 
with follow-up beyond 12 months are required to appropriately map the trajectory of 288 
recovery after THA and determine the effect of surgery on gait function in the long term. 289 
Furthermore, greater consistency of reporting of gait parameters would facilitate easier 290 
comparison across studies, particularly for kinetic gait parameters. Unfortunately 291 
inconsistency in reporting precluded meta-analysis of most joint moment parameters. A 292 
greater understanding the effect of THA on muscle function in future studies will shed light 293 


















Certain limitations of this review should be acknowledged. First, all study designs were 295 
included in the review to determine the changes in gait biomechanics following THA and 296 
compared to healthy individuals. Therefore, this review is susceptible to bias through the 297 
inclusion of lower level study designs. However, we undertook an established grading of 298 
evidence that considers study risk of bias, magnitude of the effect size and heterogeneity to 299 
synthesise the findings. Second, the studies included to evaluate the change in gait from 300 
pre- to post-operative status were not synonymous with the studies included to compare 301 
post-operative gait to healthy individuals due to the limited number of longitudinal studies 302 
that included a control group. Therefore, direct comparison between the two separate 303 
analyses is cautioned. Some of the meta-analyses were based on a smaller number of 304 
studies of varying methodological quality, although the regression analyses indicated the 305 
risk of bias scores could not explain any observed heterogeneity.  Finally, only studies 306 
published in English were included due to limited translation resources. Therefore it is 307 
uncertain if inclusion of non-English studies would alter the outcomes of the review. 308 
Conclusion 309 
Compared with OA patients before surgery THA was successful in improving walking speed, 310 
step length, stride length, single-limb support time, sagittal and coronal plane hip ROM. 311 
Despite these observed improvements from pre-operative OA individuals, patients 312 
continued to demonstrate deficiencies compared to healthy individuals for walking speed, 313 
stride length, single limb support time and sagittal plane hip ROM at 12 months. Improved 314 
understanding of the trajectories of recovery in gait function after THA may assist in 315 
managing expectations for both patients and clinicians, with further research required to 316 
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Figure 1. Flowchart of study selection process 
Figure 2. A (left) illustrates the change in walking speed following THA compared to the pre-
operative status. B (right) compares post-operative THA patients to healthy individuals. 
Studies listed as (Author) a, b, c represent different surgical approaches used and reported 
in the study. 
Figure 3. A (left) illustrates the change in step length following THA compared to the pre-
operative status. B (right) compares post-operative THA patients to healthy individuals. 
Studies listed as (Author) a, b, c represent different surgical approaches used and reported 
in the study. 
Figure 4. A (top) illustrates the change in sagittal plane hip flexion/extension ROM following 
THA compared to the pre-operative status. B (bottom) compares post-operative THA 
patients to healthy individuals. Studies listed as (Author) a, b, c represent different surgical 
approaches used and reported in the study. 
Figure 5. A (top) illustrates the change in coronal plane hip abduction/adduction ROM 
following THA compared to the pre-operative status. B (bottom) compares post-operative 
THA patients to healthy individuals. Studies listed as (Author) a, b, c represent different 





























Controls Patients (THA) Controls Patients (THA) Controls  
  
Agostini et al 2014 
27
 Case control   20  20 66.1 ± 7.2 65.4 ± 5.1 M = 26.1 ± 2.1;  
F = 27.7 ± 5.0 
M = 24.4 ± 3;  
F = 23.2 ± 2.5 
Posterolateral 3 mo, 6 mo, 12 mo 22 
Ajemian et al 2004 
35
 Case series    11 N/A 
 




Not specified Pre-op, 4 mo, 8 mo 12 
Aminian et al 1999 
36
 Case series    12 N/A 
 
64.5 ± 8.7 N/A 
 
27.8 ± 2 N/A 
 
Not specified Not specified 11 
Atallah et al 2014 
37




65.9 ± 6.5 
 






Not specified Not specified 15 
Beaulieu et al 2010 
38




66.2 ± 6.7 
 
63.5 ± 4.4 
 
27.2 ± 5 
 
24.9 ± 3.5 Lateral 6-15 mo 19 
Behery and Foucher 2014 
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 Case series    125 N/A 
 
61 ± 10 N/A 
 
28.2 ± 5 N/A 
 
Not specified Pre-op, 15 mo 7 
Bennett et al 2008 
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Posterior 9-10 mo 18 
Bennett et al 2006 
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b: Posterior (small incision) 
Pre-op, 1.38 mo 14 
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mo 
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Bhargava et al 2007 
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Bianchi et al 2012 
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Bouffard et al 2011 
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head) 
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Casartelli et al 2013 
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≠
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da Cunha et al 2016 
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Foucher 2016 
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Foucher et al 2015 
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Foucher et al 2010 
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Foucher et al 2011 
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18 mo, 2 y, 3 y, 4 y, 5 
y, 6 y 
15 








55 ± 6 
 
57 ± 7 
 
28.4 ± 2.8 
 




Pre-op, 2 mo, 6 mo 22 
Jensen et al 2014 
54
 Case series    38 N/A 
 
56 ± 5.6 N/A 
 
27.8 ± 3.6 N/A 
 
Not specified Pre-op, 2 mo, 6 mo 11 
Judd et al 2015 
55
 Case series    5 N/A 
 
62.4 ± 7.3 N/A 
 
31.84 ± 4.3 N/A 
 
Posterior Pre-op, 8 wk 19 
Kanzaki et al 2008 
56




46.3 ± 12.4 
 
48.9 ± 8.2 
 
20.6 ± 2.5 
 
19.6 ± 1.7 
 
Anterolateral (Dall’s) 4 wk, 6 mo 18 









a: 71.3 ± 3.7 
b: 70.1 ± 1.4 
 
70.8 ± 3.1 
 
a: 29.9 ± 2.4 
b: 29.8 ± 1.6 
 




Pre-op, 3 mo, 6 mo, 12 
mo 
23 









a: 57 ± 7.3 
b: 56.9 ± 3.3 
 
59.9 ± 5.3 
 
a: 31.1 ± 4.1 
b: 32 ± 5.1 
 




Pre-op, 6 wk, 4 mo 21 
Krych et al 2011 
58





a: 64.5 ± 13.4 




a: 29.38 ± 6.5 




a: Posterior (mini-incision) 
b: Two incision (anterior and 
buttock) 
Pre-op, 2 mo, 12 mo 21 
Krych et al 2010 
59






Total 63 ± 13 
a: NR  










a: Posterior (mini-incision) 
b: Two incision (anterior and 
buttock) 
Pre-op, 6 wk 15 








49.8 ± 7.3 
 
44.4 ± 6.3 
 
27.8 ± 3.9 
 
25.8 ± 2.9 
 
Posterior Pre-op 3 mo, 6 mo, 12 
mo 
24 
Lenaerts et al 2009 
61
 Case series    20 N/A 
 
63 ± 9.8 N/A 
 
27.4 ± 3.9 N/A 
 
Lateral Pre-op, 6 wk 15 
Li et al 2015 
62




64 ± 2.7 
 
58 ± 1.5 
 
30.7 ± 1.5 
 
24.5 ± 0.7 
 
Not specified > 12 mo 14 
Li et al 2014 
63




64.27 ± 2.8 
 
44.97 ± 2 
 
30.74 ± 1.5 
 
24.72 ± 0.4 
 
Anterior > 12 mo 14 
Loizeau et al 1995 
64




67.3 ± 8 
 






Not specified 3.8 y 16 








57 ± 5.2 
 
59.9 ± 5.3 
 
31.9 ± 4.3 
 




 Pre-op, 6 wk, 4 months 22 









a: 56.9 ± 3.4 
b: 57 ± 7.3 
 
59.9 ± 5.3 
 
a: 32 ± 5.1 
b: 31.1 ± 4.1 
 




Pre-op, 6 wk, 4 mo 22 
Madsen et al 2004 
67




a: 60.7 ± 8.4 
b: 63.6 ± 8 





















   
Maffiuletti et al 2009 
30





a: 69 ± 5 
b: 68 ± 6 
 
69 ± 4 
 
a: 27.2 ± 4.2 
b: 25.6 ± 3.3 
 




6 mo 21 
Mantovani et al 2012 
68





a: 60.5 ± 6 
b: 66.2 ± 6.7 
 
63.5 ± 4.4 
 
a: 28.5 ± 4.9 
b: 27.2 ± 5 
 








Martinez-Ramirez et al 2014 
69
 Case series    19 N/A 
 




Not specified Pre-op, 6-8 mo 17 









a: 66 ± 10 
b: 68 ± 10 
 
27.9 ± 3.3 
 
a: 27 ± 3.8 






Pre-op, 6 weeks, 3 mo 22 
McCrory et al 2001 
70




59.7 ± 13.8 
 






Not specified 10.5 mo 16 
Meneghini et al 2008 
71






a: 54 ± 9 
b: 54 ± 9 




a: 26 ± 2.3 
b: 26 ± 2.3 




a: Two incision (anterior and 
buttock) 
b: Posterior (mini incision) 
c: Anterolateral (mini incision) 
Pre-op, 6 wk 20 
Miki et al 2004 
72
 Case series    17 N/A 
 




Posterior Pre-op, 1 mo, 3 mo, 6 
mo, 12 mo 
20 
Muller et al 2012 
73





a: 64.3 ± 7 




a: 26.9 ± 3.3 





b: Direct lateral 
Pre-op, 3 mo 22 
Nankaku et al 2012 
74




47.7 ± 10 
 
47.4 ± 15.3 
 
20.4 ± 2.1 
 
20.8 ± 1.9 
 
Direct lateral (Dall’s) 4 weeks 18 
Nankaku et al 2007 
75




47 ± 10.2 
 
46 ± 13.2 
 
20.3 ± 2.2 
 
20.7 ± 1.9 
 
Anterolateral (Dall’s) 4 weeks 20 
Nantel et al 2009 
76




49 ± 7.5 
 
48.6 ± 6 
 
29.9 ± 6.6 
 
26.4 v 3.4 
 
Posterior 6 weeks 21 
Perron et al 2000 
12




65.6 ± 6 
 








 10.7 mo 17 
Queen et al 2011 
10






a: 58 ± 7 
b: 55.3 ± 8.2 













Pre-op, 6 weeks 20 
Queen et al 2013 
77






a: 60 ± 6.5 
b: 57 ± 6.2 













Pre-op, 6 weeks, 12 
mo 
19 
Rathod et al 2014 
78





a: 58 ± 6.7 




a: 25.9 ± 2.2 






Pre-op, 6 mo, 12 mo 24 








60.5 ± 9.5 
 
65.8 ± 6 
 
26.2 ± 3.5 
 
23.9 ± 3.2 
 









66.4 ± 6.9 
 






Anterolateral >  12mo 15 








64.6 ± 7.7 
 






Lateral Pre-op, 14.4 wk, 27.8 
wk 
13 








51.9 ± 10.1 
 






Posterolateral Pre-op, 3 mo 20 
Sicard-Rosenbaum et al 2002 
11




59.9 ± 14.9 
 






Not specified 23.6 mo 14 
Stansfield and Nicol 2002 
83
 Case control   5 
 
M = 5;  
F = 6 
52.6 ± 6.6 
 
M = 49.4 ± 5;  
F = 49.7 ± 5.2 
NR 
 
M = NR; 
F = NR 













   
Talis et al 2008 
84




56 ± 10 
 






Not specified 19 mo 17 




  43 
 
26 59.7 ± 7.9 
 






Posterolateral Pre-op, 2 mo, 6 mo, 12 
mo 
20 
Tateuchi et al 2011 
31




63.2 ± 7.2 
 
63.4 ± 5.1 
 
22.5 ± 3.3 
 
21.6 ± 2.1 
 
Not specified > 6 mo 18 









62 ± 12.6 
 
61.7 ± 9.4 
 
26.4 ± 3.3 
 
24.9 ± 2.3 
 
Not specified Pre-op, 6 weeks, 6 mo 19 
Varin et al 2013 
87





a: 66.2 ± 6.7 
b: 60.5 ± 6 
 
63.5 ± 9.4 
 
a: 27.2 ± 5 
b: 28.5 ± 4.9 
 







Vogt et al 2004 
88












Posterolateral 6 weeks 13 
Vogt et al 2003 
89




61.5 ± 6.7 
 






Not specified 6 weeks 16 
Waldman and Foucher 2012 
90
 Case series    132 N/A 
 
60.5 ± 10 N/A 
 
28.5 ± 4 N/A 
 
Not specified Pre-op, 12 mo 8 
Ward et al 2008 
91







a: 55 ± 2 
b: 64 ± 2 
c: 61 ± 2 




a: 28.9 ± 1.2 
b: 27.8 ± 1.1 
c: 29.8 ± 1 




a: Anterolateral (mini incision) 
b: Anterolateral (Judet mini 
incision) 
c: Posterior 
d: Posterior (mini incision) 
Pre-op, 6 weeks, 6 mo 14 
Wesseling et al 2016 
92




47.75 ± 13.2 
 
53 ± 5 
 
25.52 ± 3 
 
23.67 ± 3 
 
Anterior 12 mo 17 









a: 64.21± 10.9 
b: 60.46 ± 11.5 
 







a: Direct lateral 
b: Posterior 
Not stated 10 










a: 59 ± 7.3 
b: 55.7 ± 9.9 
c: 57 ± 11.8 
 
53.8 ± 6.5 
 
a: 26.7 ± 2.2 
b: 28.9 ± 3.8 
c: 30.7 ± 6.6 
 
26.1 ± 4.9 
 
a: Two incision (anterior and 
buttock) 
b: Anterolateral (mini incision) 
c: Posterolateral (mini 
incision) 
6 weeks, 3 mo 16 
















Table 1. Summary of findings for gait parameters across each time point. Change from pre-operative to post-operative and comparison of post-operative THA patients to 
healthy individuals 
Pre-operative vs post-operative  Post-operative THA patients vs healthy individuals 







, % SMD (95% CI) Strength of 
 evidence* 
Follow-up time points 






, % SMD (95% CI) Strength of 
evidence* 
6 weeks      6 weeks   
Velocity 20 70 0.32 (0.14 – 0.50) Moderate Velocity 13 69 -1.81 (-2.22 to -1.40) Moderate 
Single limb support time 5 36 0.44 (0.19 – 0.69) Moderate Single limb support time 6 79 -0.72 (-1.38 to -0.05) Moderate 
Double limb support time 3 50 -0.03 (-0.46 to 0.40) Moderate Double limb support time 3 91 2.22 (0.26 – 4.19) Moderate 
Stride length 11 87 0.40 (0.19 – 0.61) Moderate Stride length 8 61 -1.90 (-2.43 to -1.37) Moderate 
Stride time 3 70 0.04 (-0.13 to 0.20) Moderate Step width 5 0 1.33 (0.91 – 1.75) Strong 
Step width 5 66 0.05 (-0.25 to 0.35) Strong Step length 2 49 -1.36 (-1.90 to -0.83) Moderate 
Step length 10 75 0.41 (0.23 – 0.59) Moderate Hip flexion/extension ROM 4 0 -2.59 (-3.11 to -2.06) Moderate 
Hip flexion/extension ROM 4 88 0.49 (-0.29 to 1.27) Moderate Hip abduction/adduction ROM 4 44 -1.76 (-2.36 to -1.15) Moderate 
Hip abduction/adduction ROM 4 39 0.33 (-0.19 to 0.86) Strong Hip internal/external ROM 4 13 0.18 (-0.23 to 0.59) Moderate 
Hip internal/external ROM 4 9 0.36 (0.05 – 0.67) Strong      
3 months   3 months     
Velocity 17 63 0.78 (0.57 – 0.99) Moderate Velocity 10 82 -1.22 (-1.83 to -0.61) Moderate 
Single limb support time 5 28 0.59 (0.35 – 0.82) Strong Single limb support time 4 78 -0.73 (-1.59 to 0.12) Moderate 
Stride length 7 51 0.63 (0.38 – 0.88) Moderate Double limb support time 5 97 -0.28 (-2.05 to 1.58) Moderate 
Stride time 3 60 -0.38 (-0.68 to -0.07) Moderate Stride length 6 80 -1.60 (-2.45 to -0.74) Moderate 
Step width 8 90 0.02 (-0.63 to 0.66) Moderate Step width 8 94 1.90 (0.60 – 3.20) Moderate 
Step length 7 31 0.52 (0.33 – 0.71) Strong Step length 3 0 -0.88 (-0.68 to -0.01) Moderate 
Hip flexion/extension ROM 4 80 1.07 (0.31 – 1.84) Moderate Swing time 3 0 -0.39 (-0.67 to -0.11) Strong 
Hip abduction/adduction ROM 5 95 1.03 (0.24 – 1.82) Moderate Hip flexion/extension ROM 5 56 -1.88 (-2.47 to -1.28) Strong 
Hip internal/external ROM 4 89 0.50 (0.01 – 1.00) Moderate Hip abduction/adduction ROM 4 0 -1.41 (-1.83 to -0.99) Strong 
Peak hip flexion angle 3 86 0.16 (-0.47 to 0.78) Moderate Hip internal/external ROM 4 79 0.26 (-0.60 to 1.11) Moderate 
Peak hip abduction angle 2 0 -0.39 (-0.62 to -0.16) Moderate Pelvis obliquity ROM 3 99 -0.20 (-3.31 to 2.90) Moderate 
     Peak pelvis obliquity angle 4 96 -0.24 (-1.83 to 1.34) Moderate 
   Minimum pelvis obliquity angle 4 96 -0.41 (-1.96 to 1.13) Moderate 
     Peak hip abduction moment 4 21 0.02 (-0.44 to 0.49) Moderate 
6 months     6 months   













Step length 6 75 0.90 (0.50 – 1.31) Moderate Single limb support time 5 82 -0.33 (-1.08 to 0.42) Moderate 
Cadence 6 96 -0.08 (-1.05 to 0.89) Moderate Double limb support time 7 88 0.18 (-0.51 to 0.88) Moderate 
Pre-operative vs post-operative Post-operative THA patients vs healthy individuals 







, % SMD (95% CI) Strength of 
 evidence* 
Follow-up time points 






, % SMD (95% CI) Strength of 
evidence* 
Stance phase 3 34 -0.14 (-0.42 to 0.13) Limited Stride length 7 0 -0.78 (-1.06 to -0.49) Strong 
Pelvic obliquity ROM 4 98 -0.81 (-2.60 to 0.99) Moderate Step length 4 51 -0.35 (-0.68 to -0.01) Strong 
     Swing time 5 75 0.36 (-0.14 to 0.86) Moderate 
     Hip flexion/extension ROM 3 0 -1.33 (-1.83 to -0.82) Strong 
     Pelvis obliquity ROM 5 95 0.28 (-1.02 to 1.57) Moderate 
12 months     12 months   
Velocity 11 78 1.28 (1.01 – 1.56) Moderate Velocity 7 77 -0.59 (-1.08 to -0.11) Moderate 
Hip abduction/adduction ROM 4 39 0.33 (-0.19 to 0.86) Strong Single limb support time 2 0 -0.82 (-1.23 to -0.41) Moderate 
Hip internal/external ROM 4 9 0.36 (0.05 – 0.67) Strong Double limb support time 3 59 -0.38 (-0.83 to 0.08) Moderate 
     Stride length 3 0 -1.27 (-1.63 to -0.91) Moderate 
     Step length 3 90 -0.54 (-1.46 to 0.38) Moderate 
     Hip flexion/extension ROM 3 65 -1.16 (-1.83 to -0.49) Strong 
     Peak hip extension angle 4 97 0.11 (-1.68 to 1.91) Moderate 
     Pelvis obliquity ROM 4 78 0.09 (-0.47 to 0.65) Moderate 
     Pelvis flexion/extension ROM 5 73 0.48 (0.00 – 0.96) Moderate 
     24 months   
     Velocity 2 0 -0.57 (-0.98 to -0.15) Limited 
















Table 1. Meta Regression Analysis of Factors Potentially Related to Heterogeneity 
*Comparison of the gluteal muscle sparing (anterior) approach to the more conventional posterior and lateral 
surgical approaches.  
 Velocity 6 weeks Velocity 3 months Velocity 12 months Step length 6 weeks Stride length 6 weeks 
 β  (95% CI) P 
Value 
β (95% CI) P 
Value 
β (95% CI) P 
Value 
β (95% CI) P 
Value 
β (95% CI) P 
Value 
Age -0.25  
(-0.77 to 0.27) 
.324 -.052  
(-.102 to -.001) 
.046 -.094  
(-.185 to -.003) 
.045 -.029  
(-.107 to .048) 
.406 -.021  
(-.086 to .044) 
.484 
BMI -.002  
(-.106 to .102) 
.968 .055  
(-.093 to .204) 
.437 .011  
(-.867 to .889) 
.970 .255  
(-1.244 to 1.755) 
.275 -.012  





(-0.20 to .005) 
.217 -.005  
(-.019 to .010) 
.508 -.002  
(-.010 to .006) 
.583 -.011  
(-.020 to -.001) 
.033 -.034  





(-.315 to .705) 
.431 .224  
(-.532 to .981) 
.537 .725  
(-.477 to 1.927) 
.206 - - .354  
(-.290 to .998) 
.245 
% females .003  
(-.007 to .014) 
.497 -.005  
(-.017 to .007) 
.386 -.006  
(-.037 to .025) 
.645 -.016  
(-.040 to .008) 
.141 .011  
(-.012 to .034) 
.271 
Risk of bias -.047  
(-.105 to .011) 
.107 -.062  
(-.131 to .007) 
.073 .051  
(-.042 to .144) 
.246 -.041  
(-.132 to .050) 
.326 -.095  














Figure 2. A ( left) illustrates the change in walking speed following THA compared to the pre-operative status. B (right) compares post-operative THA patients to healthy individuals. Studies listed as (Author) a, b, c represent different surgical approaches 
used and reported in the study. 













van den Akker-Scheek 2007
Total (95% C I)
Heterogeneity: Tau² = 0.38; Chi² = 38.39, df = 12 (P = 0.0001); I² = 69%
Test for overall effect: Z = 8.61 (P < 0.00001)











Total (95% C I)
Heterogeneity: Tau² = 0.78; Chi² = 48.89, df = 9 (P < 0.00001); I² = 82%
Test for overall effect: Z = 3.90 (P < 0.0001)








van den Akker-Scheek 2007
Total (95% C I)
Heterogeneity: Tau² = 0.21; Chi² = 19.21, df = 7 (P = 0.008); I² = 64%
Test for overall effect: Z = 3.36 (P = 0.0008)








Total (95% C I)
Heterogeneity: Tau² = 0.33; Chi² = 26.09, df = 6 (P = 0.0002); I² = 77%
Test for overall effect: Z = 2.40 (P = 0.02)
Velocity 24 months  vs  healthy subjects
Sicard-Rosenbaum 2002
Talis 2008
Total (95% C I)
Heterogeneity: Tau² = 0.00; Chi² = 0.17, df = 1 (P = 0.68); I² = 0%
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S td. Mean Difference S td. Mean Difference


















































Total (95% C I)
Heterogeneity: Tau² = 0.03; Chi² = 11.79, df = 8 (P = 0.16); I² = 32%




























































































































Total (95% C I)
Heterogeneity: Tau² = 0.11; Chi² = 43.48, df = 16 (P = 0.0002); I² = 63%























Total (95% C I)
Heterogeneity: Tau² = 0.11; Chi² = 62.56, df = 19 (P < 0.00001); I² = 70%














































Total (95% C I)
Heterogeneity: Tau² = 0.15; Chi² = 45.09, df = 10 (P < 0.00001); I² = 78%
Test for overall effect: Z = 9.18 (P < 0.00001)
100.0%































































IV, R andom, 95% C I













Figure 3. A (left) illustrates the change in step length following THA compared to the pre-operative status. B (right) compares post-operative THA patients to healthy individuals. Studies listed as (Author) a, b, c represent different surgical approaches used and reported in the study.
Step length 6 weeks  vs  healthy subjects
Reininga 2013
van den Akker-Scheek 2007
Total (95% C I)
Heterogeneity: Tau² = 0.07; Chi² = 1.95, df = 1 (P = 0.16); I² = 49%






























Total (95% C I)
Heterogeneity: Tau² = 0.00; Chi² = 0.57, df = 2 (P = 0.75); I² = 0%

































van den Akker-Scheek 2007
Total (95% C I)
Heterogeneity: Tau² = 0.06; Chi² = 6.11, df = 3 (P = 0.11); I² = 51%









































Total (95% C I)
Heterogeneity: Tau² = 0.58; Chi² = 19.79, df = 2 (P < 0.0001); I² = 90%






























IV, R andom, 95% C I
Std. Mean Difference Std. Mean Difference
IV, R andom, 95% C I











Total (95% C I)
Heterogeneity: Tau² = 0.06; Chi² = 36.53, df = 9 (P < 0.0001); I² = 75%
Test for overall effect: Z = 4.39 (P < 0.0001)
Total (95% C I)
Heterogeneity: Tau² = 0.02; Chi² = 8.67, df = 6 (P = 0.19); I² = 31%
Test for overall effect: Z = 5.26 (P < 0.00001)







Total (95% C I)
Heterogeneity: Tau² = 0.19; Chi² = 19.91, df = 5 (P = 0.001); I² = 75%
























































IV, R andom, 95% C I
Std. Mean DifferenceStd. Mean Difference
IV, R andom, 95% C I









































































Total (95% C I)
Heterogeneity: Tau² = 0.55; Chi² = 24.14, df = 3 (P < 0.0001); I² = 88%
Test for overall effect: Z = 1.24 (P = 0.22)





Total (95% C I)
Heterogeneity: Tau² = 0.47; Chi² = 15.18, df = 3 (P = 0.002); I² = 80%









































IV, R andom, 95% C I
Std. Mean DifferenceStd. Mean Difference
IV, R andom, 95% C I





Total (95% C I)
Heterogeneity: Tau² = 0.00; Chi² = 0.79, df = 3 (P = 0.85); I² = 0%
















































Total (95% C I)
Heterogeneity: Tau² = 0.26; Chi² = 9.05, df = 4 (P = 0.06); I² = 56%

















































Total (95% C I)
Heterogeneity: Tau² = 0.00; Chi² = 1.85, df = 2 (P = 0.40); I² = 0%

































Total (95% C I)
Heterogeneity: Tau² = 0.23; Chi² = 5.79, df = 2 (P = 0.06); I² = 65%
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Std. Mean Difference Std. Mean Difference
IV, R andom, 95% C I
Figure 4. A (top) illustrates the change in sagittal plane hip flexion/extension ROM following THA compared to the pre-operative status.
B (bottom) compares post-operative THA patients to healthy individuals. Studies listed as (Author) a, b, c represent different surgical 















Figure 5. A (top) illustrates the change in coronal plane hip abduction/adduction ROM following THA compared to the pre-operative status. B (bottom) 
compares post-operative THA patients to healthy individuals.Studies listed as (Author) a, b, c represent different surgical approaches used and reported
in the study





Total (95% C I)
Heterogeneity: Tau² = 0.11; Chi² = 4.94, df = 3 (P = 0.18); I² = 39%
Test for overall effect: Z = 1.24 (P = 0.22)






Total (95% C I)
Heterogeneity: Tau² = 0.74; Chi² = 73.54, df = 4 (P < 0.00001); I² = 95%
Test for overall effect: Z = 2.56 (P = 0.01)





Total (95% C I)
Heterogeneity: Tau² = 0.11; Chi² = 4.94, df = 3 (P = 0.18); I² = 39%































































IV, R andom, 95% C I
Std. Mean DifferenceStd. Mean Difference
IV, R andom, 95% C I





Total (95% C I)
Heterogeneity: Tau² = 0.17; Chi² = 5.36, df = 3 (P = 0.15); I² = 44%














































Total (95% C I)
Heterogeneity: Tau² = 0.00; Chi² = 2.75, df = 3 (P = 0.43); I² = 0%
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  3412 Records identified through database searching  
 
1534 Records screened after duplicates removed 
 
      338 Full-text articles assessed for eligibility 
1196 Records excluded by title and abstract 
2 Articles identified from pearling  
3 Articles published after search and met criteria 
 
74 Studies included in qualitative synthesis 
269 full-text articles excluded 
59 Study design not appropriate 
45 Irrelevant reports 
43 Did not measure unassisted gait at self-selected speed 
39 Non-English 
33 Did not undergo primary unilateral THA for OA 
28 Abstract or unavailable as full text 
20 Gait data not appropriately reported (central tendency and 
variation) 




46 Studies included in quantitative synthesis 
  28 Presented/analysed pre-post changes 






Total parameters reported n = 20 
Included for meta-analyses 
THA vs OA (pre vs post) n = 9 






Total parameters reported n = 56 
Included for meta-analyses 
THA vs OA (pre vs post) n = 6 






  Total parameters reported n = 54 
Included for meta-analyses 
THA vs OA (pre vs post) n = 0 
  THA vs control n = 1 
 
 
 
 
